Skip to main content
Fig. 9 | Journal of Translational Medicine

Fig. 9

From: Personalizing the safe, appropriate and effective concentration(s) of ozone for a non-diabetic individual and four type II diabetic patients in autohemotherapy through blood hemoglobin analysis

Fig. 9

Size distribution revealed by DLS of ozonated whole blood oxy-Hb from five human samples. a DLS profiles of oxy-Hb for the non-diabetic individual A. be DLS profiles of oxy-Hb for the diabetic patients B to E, respectively. Column 1—non-ozonated Hb for each individual; Column 2—Hb samples ozonated at 15 μg/ml; Column 3—Hb samples ozonated at 35 μg/ml; and Column 4—Hb samples ozonated at 55 μg/ml. The peak diameter values are given in nanometers. For intensity mode values and percentage intensity please refer to Table 2

Back to article page